Binance Coin (BNB) broke its all-time high, reaching $880, fueled by surging institutional interest. This surge comes as Binance’s BNB token burns continue to grow and alongside increased demand from institutional investors. In contrast, Windtree Therapeutics experienced a dramatic 77% stock decline following its Nasdaq delisting. This event highlights the power of institutional allocation within the cryptocurrency market and raises questions about the risks associated with biotech firms venturing into digital assets. 2025’s volatility has been particularly visible in the biotech sector after Windtree’s significant investment in BNB, which may have contributed to their downfall.